Why the study?
Are mid-trimester maternal serum AFP and hCG levels associated with adverse pregnancy outcomes in healthy women?
Are mid-trimester maternal serum AFP and hCG levels associated with adverse pregnancy outcomes in healthy women?
Mid-trimester multiparameter testing including ms-AFP and ms-hCG may help identify women at increased risk for pregnancy complications.
OBJECTIVE: In a prospective study, we investigated the association between mid-trimester maternal serum AFP (ms-AFP), maternal serum hCG (ms-hCG) levels and adverse pregnancy outcome in a South-Western Greek population. MATERIALS AND METHODS: 126 healthy Greek women with spontaneous pregnancies were investigated for ms-AFP and ms-hCG levels between the 13th and 24th weeks of gestation and followed for adverse pregnancy outcome. Abnormal outcomes were considered as ms-AFP levels or ms-hCG levels > 2.0 multiples of the median value for gestation (MoM). Statistical analysis was performed by Pearson's chi-square test. RESULTS: Elevated ms-AFP levels were detected in a total of 25 out of the 126 women studied (19.84%). Elevated ms-hCG levels were detected in a total of ten of the 126 women studied (7.93%). Elevated ms-AFP and ms-hCG levels were detected in a total of four of the 126 women studied (3.17%). CONCLUSION: Multiparameter testing of placental function in the mid-trimester (uterine artery Doppler, placental morphology, ms-AFP and ms-hCG screening) may allow us to identify women with increased risk of developing severe placental insufficiency and pregnancy complications.
No takes yet. Share an insight, caveat, or question.
Mahoney et al. (1958) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: